drugset

drugset / Trial / NCT01268761

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

NCT01268761 ↗

Phase 3 Completed 100 enrolled Instituto Valenciano de Infertilidad, IVI VALENCIA

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to analyze the effectiveness of GnRh antagonist in the treatment of early ovarian hyperstimulation syndrome.

Timeline

Start: 2012-04
Primary completion: 2013-07
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cetrorelix	Other / unclassified	—	—

Indications